Rabab Hamed Sayed

18PUBLICATIONS
20CO-AUTHORS
Gene and molecular therapyMolecular targetsMolecular medicineBioavailability and ecotoxicologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 19, 2026
The Neuroprotective Effects of Agomelatine in a 3‑Nitropropionic Acid-Induced Rat Model of Huntington's Disease via Brain-Derived Neurotrophic Factor (BDNF)/tropomyosin-Related Kinase Receptor Type B (TrKB)/Phosphoinositide 3‑Kinase (PI3K)/Protein Kinase B (AKT) Activation and Rho-Associated Protein Kinase 1 (ROCK1) Pathway Inhibition.

Hossam H Abouzaid, Rabab H Sayed, Walaa Wadie

|Feb 14, 2026
The protective effect of febuxostat in a rotenone mouse model of Parkinson's disease: the interplay between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 signaling pathways.

Kholoud Mohamed Lasheen, Zeinab Mohammad, Nouran Ahmed

|Sep 29, 2025
Targeting JNK1/2 and P38 Mitogen-Activated Protein Kinases With Pazopanib Mitigates Bleomycin-Induced Lung Fibrosis.

Rasha Abdelhady, Rabab H Sayed, Nancy S Younis

|Sep 29, 2025
The Role of the AMY1 Receptor Signaling Cascade in the Protective Effect of Sulforaphane Against Nitroglycerin-Induced Migraine in Mice.

Luejine A Elbendary, Ghada A Abdel-Latif, Mohamed A Khattab

|Jul 27, 2024
Correction to: 17β-Estradiol augments the neuroprotective effect of agomelatine in depressive- and anxiety-like behaviors in ovariectomized rats.

Yasmine A El-Khatib, Rabab H Sayed, Nada A Sallam

|Dec 25, 2023
Ezetimibe ameliorates cisplatin-induced nephrotoxicity: A novel therapeutic approach via modulating AMPK/Nrf2/TXNIP signaling.

Nevine Fathy, Shaimaa Farouk, Rabab H Sayed

Pageof 3

Frequent Collaborators

1 joint publications

Marwa M Saeed

1 joint publications

Álvaro Fernández-Ochoa

1 joint publications

Fatema R Saber

1 joint publications

María de la Luz Cádiz-Gurrea